Neural membranes are composed of glycerophospholipids, sphingolipids, cholesterol, and proteins. Glycerophospholipids and sphingolipids contain nonpolar fatty acyl, alkenyl, and alkyl chains. The degree of unsaturation in polyunsaturated fatty acids (PUFA) determines many neural membrane properties including membrane order, packing pattern, and fluidity. Variations in the head group, length of the fatty acid acyl chains, and degree of saturation and unsaturation produce changes in surface charge and physicochemical characteristics of neural membranes. Collective evidence suggests that PUFA modulate many neural membrane properties and functions (Yehuda et al., 2002; Farooqui and Horrocks, 2007; Farooqui, 2009). Three families of PUFA are known to occur in neural membranes: the n–3 PUFA family is characterized by having their first double bond at carbon atom number 3; n–6 PUFA family members have their first double bond at carbon atom number 6, when counted from the methyl end of the carbon chain; and n–9 family member contains first double bond at carbon atom number 9 from fatty acid methyl end. Examples of n–3 fatty acids are α-linolenic acid (ALA; 18:3n–3) acid, eicosapentaenoic acid (EPA; 20:5n–3), and docosahexaenoic acid (DHA; 22:6n–3). Examples of n–6 fatty acid family are linoleic acid (LA; 18:2n–6), arachidonic acid (ARA; 20:4n–6), and adrenic acid (AA; 22:4n–6), and example of n–9 family is oleic acid. Mammals cannot introduce double bond between carbon 1 and 6 due to the lack of desaturases but can introduce a double bond after the ninth carbon through the action of Δ9-desaturase. In mammalian synaptosomal plasma membrane glycerophospholipids, n–6 and n–3 PUFA are mainly located at the sn-2 position of glycerol moiety. Majority of ARA and oleic acid is associated with phosphatidylcholine (PtdCho), whereas phosphatidylethanolamine (PtdEtn) and ethanolamine plasmalogens (PlsEtn) contain both ARA and DHA at the sn-2 position of glycerol moiety. Phosphatidylserine (PtdSer) is enriched in DHA (Glomset, 2006). Sphingomyelin and glycolipids in synaptosomal plasma membranes contain amide-linked stearic acid instead of a mixture of this acid with other amide-linked fatty acids. Although the physiological significance of this unique distribution of lipid head groups, esterified fatty acids, and amide-linked fatty acids is not fully understood, asymmetric distribution of glycerophospholipids and sphingolipids between the two leaflets of neural membrane may contribute to dynamic lipid substructures (Glomset, 2006). In neural membranes, DHA and ARA are substrates for lipid mediators. LA and ALA are precursors for the synthesis of ARA and DHA, respectively. The importance of ARA and DHA is related to their specific interactions with membrane proteins and their ability to serve as precursors for eicosanoids and docosanoids. Collective evidence suggests that the incorporation of ARA and DHA in neural membranes not only induces changes in physicochemical properties of membranes but also modulates membrane functions through the generation of lipid mediators (Horrocks and Farooqui, 2004).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Akbar M., and Kim H.Y. (2002). Protective effects of docosahexaenoic acid in staurosporine-induced apoptosis: involvement of phosphatidylinositol-3 kinase pathway. J. Neurochem. 82:655–665.
Baker R.A., and Chang H.Y. (1981). A comparison of lysophosphatidylcholine acyltransferase activities in neuronal nuclei and microsomes isolated from immature rabbit cerebral cortex. Biochim. Biophys. Acta. 666:223–229.
Bezard J., Blond J.P., Bernard A., and Clouet P. (1994). The metabolism and availability of essential fatty acids in animal and human tissues. Reprod. Nutr. Dev. 34:539–568.
Bourre J.M., Durand G., Pascal G., and Youyou A. (1989). Brain cell and tissue recovery in rats made deficient in n-3 fatty acids by alteration of dietary fat. J. Nutr. 119:15–22.
Bourre J.M., and Piciotti M. (1992). Delta-6 desaturation of alpha-linolenic acid in brain and liver during development and aging in the mouse. Neurosci. Lett. 141:65–68.
Cabrini L., Bochicchio D., Bordoni A., Sassi S., Marchetti M., and Maranesi M. (2005). Correlation between dietary polyunsaturated fatty acids and plasma homocysteine concentration in vitamin B6-deficient rats. Nutr. Metab. Cardiovasc. Dis. 15:94–99.
Cao J., Blond J.P., and Bezard J. (1993). Inhibition of fatty acid delta 6- and delta 5-desaturation by cyclopropene fatty acids in rat liver microsomes. Biochim. Biophys. Acta. 1210:27–34.
Cao Y., Murphy K.J., McIntyre T.M., Zimmerman G.A., and Prescott S.M. (2000). Expression of fatty acid-CoA ligase 4 during development and in brain. FEBS Lett. 467:263–267.
Cao J., Liu Y., Lockwood J., Burn P., and Shi Y. (2004). A novel cardiolipin-remodeling pathway revealed by a gene encoding an endoplasmic reticulum-associated acyl-CoA:lysocardiolipin acyltransferase (ALCAT1) in mouse. J Biol. Chem. 279:31727–31734.
Cao J., Shan D., Revett T., Li D., Wu L., Liu W., Tobin J., and Gimeno R.E. (2008). Molecular Identification of a novel mammalian brain isoform of Acyl-CoA:Lysophospholipid acyltransferase with prominent ethanolamine lysophospholipid acylating activity, LPEAT2. J. Biol. Chem. 283:19049–19057.
Castagnet P.I., and Giusto N.M. (1997). Acyl-CoA:lysophosphatidylcholine acyltransferase activity in bovine retina rod outer segments. Arch. Biochem. Biophys. 340:124–134.
Chen C.T., Green J.T., Orr S.K., and Bazinet R.P. (2008). Regulation of brain polyunsaturated fatty acid uptake and turnover. Prostaglandins Leukot. Essent. Fatty Acids 79:85–91.
Cho H.P., Nakamura M., and Clarke S.D. (1999a). Cloning, expression, and fatty acid regulation of the human delta-5 desaturase. J. Biol. Chem. 274:37335–37339.
Cho H.P., Nakamura M., and Clarke S.D. (1999b). Cloning, expression, and nutritional regulation of the mammalian Delta-6 desaturase. J. Biol. Chem. 274:471–477.
Coleman R.A., Lewin T.M., and Muoio D.M. (2000). Physiological and nutritional regulation of enzymes of triacylglycerol synthesis. Annu. Rev. Nutr. 20:77–103.
Contreras M.A., Sheaff-Greiner R., Chang M.C.J., Myers C.S., Salem N. Jr., and Rapoport S.I. (2000). Nutritional deprivation of alpha-linolenic acid decreases but does not abolish turnover and availability of unacylated docosahexaenoic acid and docosahexaenoyl-CoA in rat brain. J. Neurochem. 75:2392–2400.
Contreras M.A., Chang M.C.J., Rosenberger T.A., Greiner R.S., Myers C.S., Salem N. Jr., and Rapoport S.I. (2001). Chronic nutritional deprivation of n-3 alpha-linolenic acid does not affect n-6 arachidonic acid recycling within brain phospholipids of awake rats. J Neurochem. 79:1090–1099.
Corbin D.R., and Sun G.Y. (1978). Characterization of the enzymic transfer of arachidonoyl groups to 1-acyl-phosphoglycerides in mouse synaptosome fraction. J. Neurochem. 30:77–82.
Corkey B.E., Deeney J.T., Yaney G.C., Tornheim K., and Prentki M. (2000). The role of long-chain fatty acyl-CoA esters in beta-cell signal transduction. J. Nutr. 130(2S Suppl):299S–304S.
Crawford M.A. (2006). Docosahexaenoic acid in neural signaling systems. Nutri. Health 18:263–276.
Das U.N. (2007). A defect in the activity of Δ6 and Δ5-desaturases may be a factor in the initiation and progression of atherosclerosis. Prostaglandins Leukot. Essent. Fatty Acids 76:251–268.
DeGeorge J.J., Noronha J.G., Bell J., Robinson P., and Rapoport S.I. (1989). Intravenous injection of [1–14C]arachidonate to examine regional brain lipid metabolism in unanesthetized rats. J. Neurosci. Res. 24:413–423.
Deka N., Sun G.Y., and MacQuarrie R. (1986). Purification and properties of acyl-CoA:1-acyl-sn-glycero-3-phosphocholine-O-acyltransferase from bovine brain microsomes. Arch. Biochem. Biophys. 246:554–563.
DeMar J.C.J., Ma K.Z., Bell J.M., and Rapoport S.I. (2004). Half-lives of docosahexaenoic acid in rat brain phospholipids are prolonged by 15 weeks of nutritional deprivation of n-3 polyunsaturated fatty acids. J. Neurochem. 91:1125–1137.
Denys A., Hichami A., and Khan N.A. (2005). n-3PUFAs modulate T-cell activation via protein kinase C-α and -ε and the NF-κ B signaling pathway. J. Lipid Res. 46:752–758.
Dutta-Roy A.K. (2000). Transport mechanisms for long-chain polyunsaturated fatty acids in the human placenta. Am. J. Clin Nutr. 71(1 Suppl):315S–322S.
Faergeman N.J., and Knudsen J. (1997). Role of long-chain fatty acyl-CoA esters in the regulation of metabolism and in cell signalling. Biochem. J. 323:1–12.
Farooqui A.A., Horrocks L.A., and Farooqui T. (2000a). Deacylation and reacylation of neural membrane glycerophospholipids. J. Mol. Neurosci. 14:123–135.
Farooqui A.A., Horrocks L.A., and Farooqui T. (2000b). Glycerophospholipids in brain: their metabolism, incorporation into membranes, functions, and involvement in neurological disorders. Chem. Phys. Lipids 106:1–29.
Farooqui A.A., and Horrocks L.A. (2001a). Plasmalogens, phospholipase A2, and docosahexaenoic acid turnover in brain tissue. J. Mol. Neurosci. 16:263–272.
Farooqui A.A., and Horrocks L.A. (2001b). Plasmalogens: workhorse lipids of membranes in normal and injured neurons and glia. Neuroscientist 7:232–245.
Farooqui A.A., and Horrocks L.A. (2006). Phospholipase A2-generated lipid mediators in the brain: the good, the bad, and the ugly. Neuroscientist 12:245–260.
Farooqui A.A., and Horrocks L.A. (2007). Glycerophospholipid Metabolism in Brain. Springer, New York.
Farooqui A.A., Ong W.Y., and Horrocks L.A. (2008). Neurochemical Aspects of Excitotoxicity. Springer, New York.
Farooqui A.A. (2009). Hot Topics in Neural Membrane Lipidology. Springer New York.
Ferrier G.R., Redondo I., Zhu J.Q., and Murphy M.G. (2002). Differential effects of docosahexaenoic acid on contractions and L-type Ca2+ current in adult cardiac myocytes. Cardiovasc. Res. 54:601–610.
Fonlupt P., Croset M., and Lagarde M. (1994). Incorporation of arachidonic and docosahexaenoic acids into phospholipids of rat brain membranes. Neurosci. Lett. 171:137–141.
Galli C., and Rise P. (2006). Origin of fatty acids in the body: endogenous synthesis versus dietary intake. Eur. J. Lipid Sci. 108:521–525.
Garcia M.C., Ward G., Ma Y.C., Salem N. Jr., and Kim H.Y. (1998). Effect of docosahexaenoic acid on the synthesis of phosphatidylserine in rat brain in microsomes and C6 glioma cells. J. Neurochem. 70:24–30.
Glatz J.F., Luiken J.J., and Bonen H. (2001). Involvement of membrane-associated proteins in the acute regulation of cellular fatty acid uptake. J. Mol. Neurosci. 16:123–132.
Glomset J.A. (2006). Role of docosahexaenoic acid in neuronal plasma membranes. Sci STKE 2006:pe6.
Green J.T., Orr S.K., and Bazinet R.P. (2008). The emerging role of group VI calcium-independent phospholipase A2 in releasing docosahexaenoic acid from brain phospholipids. J. Lipid Res. 49:939–944.
Green P., and Yavin E. (1993). Elongation, desaturation, and esterification of essential fatty acids by fetal rat brain in vivo. J. Lipid Res. 34:2099–2107.
Greenwalt D.E., Scheck S.H., and Rhinehart-Jones T. (1995). Heart CD36 expression is increased in murine models of diabetes and in mice fed a high fat diet. J. Clin. Invest. 96:1382–1388.
Gronn M., Christensen E., Hagve T.A., and Christophersen B.O. (1992). Effects of dietary purified eicosapentaenoic acid (20:5 (n-3)) and docosahexaenoic acid (22:6(n-3)) on fatty acid desaturation and oxidation in isolated rat liver cells. Biochim. Biophys. Acta. 1125:35–43.
Grossfield A., Feller S., and Pitman M.C. (2006). A role for direct interactions in the modulation of rhodopsin by omega-3 polyunsaturated lipids. Proc. Nat. Acad. Sci USA 103:4888–4893.
Hamano H., Nabekura J., Nishikawa M., and Ogawa T. (1996). Docosahexaenoic acid reduces GABA response in substantia nigra neuron of rat. J. Neurophysiol. 75:1264–1270.
Hamilton J.A., and Brunaldi K. (2007). A model for fatty acid transport into the brain. J. Mol. Neurosci. 33:12–17.
Hishikawa D., Shindou H., Kobayashi S., Nakanishi H., Taguchi R., and Shimizu T. (2008). Discovery of a lysophospholipid acyltransferase family essential for membrane asymmetry and diversity. Proc. Natl. Acad. Sci. USA 105:2830–2835.
Horrocks L.A. (1972). Content, composition, and metabolism of mammalian and avian lipids that contain ether groups. In: Snyder F. (ed.), Ether Lipids: Chemistry and Biology, pp. 177–272. Academic Press, New York.
Horrocks L.A., and Farooqui A.A. (2004). Docosahexaenoic acid in the diet: its importance in maintenance and restoration of neural membrane function. Prostaglandins Leukot. Essent. Fatty Acids 70:361–372.
Hu Z., Dai Y., Prentki M., Chohnan S., and Lane M.D. (2005). A role for hypothalamic malonyl-CoA in the control of food intake. J. Biol. Chem. 280:39681–39683.
Huster, D., Arnold, K., and Gawrisch, K. (1998). Influence of docosahexaenoic acid and cholesterol on lateral lipid organization in phospholipids mixtures. Biochemistry 37: 17299–17308.
Igarashi M., Ma K., Chang L., Bell J.M., and Rapoport S.I. (2007a). Dietary n-3 PUFA deprivation for 15 weeks upregulates elongase and desaturase expression in rat liver but not brain. J Lipid Res. 48:2463–2470.
Igarashi M., De Mar J.C. Jr., Ma K., Chang L., Bell J.M., and Rapoport S.I. (2007b). Docosahexaenoic acid synthesis from alpha-linolenic acid by rat brain is unaffected by dietary n-3 PUFA deprivation. J. Lipid Res. 48:1150–1158.
Ikemoto A., Ohishi M., Hata N., Misawa Y., Fujii Y., and Okuyama H. (2000). Effect of n-3 fatty acid deficiency on fatty acid composition and metabolism of aminophospholipids in rat brain synaptosomes. Lipids 35:1107–1115.
Infante J.P., and Huszagh V.A. (1997). On the molecular etiology of decreased arachidonic (20:4n-6), docosapentaenoic (22:5n-6) and docosahexaenoic (22:6n-3) acids in Zellweger syndrome and other peroxisomal disorders. Mol. Cell. Biochem. 168:101–115.
Infante J.P., and Huszagh V.A. (1998). Analysis of the putative role of 24-carbon polyunsaturated fatty acids in the biosynthesis of docosapentaenoic (22:5n-6) and docosahexaenoic (22:6n-3) acids. FEBS Lett. 431:1–6.
Innis S.M., and Dyer R.A. (2002). Brain astrocyte synthesis of docosahexaenoic acid from n-3 fatty acids is limited at the elongation of docosapentaenoic acid. J. Lipid Res. 43:1529–1536.
Jackson S.K., Abate W., Parton J., Jones S., and Harwood J.L. (2008a). Lysophospholipid metabolism facilitates Toll-like receptor 4 membrane translocation to regulate the inflammatory response. J. Leuko. Biol. 84:86–92.
Jackson S.K., Abate W., and Tonks A.J. (2008b). Lysophospholipid acyltransferases: Novel potential regulators of the inflammatory response and target for new drug discovery. Pharmacol. Ther. 119:104–114.
Jones C.R., Arai T., and Rapoport S.I. (1997). Evidence for the involvement of docosahexaenoic acid in cholinergic stimulated signal transduction at the synapse. Neurochem. Res. 22:663–670.
Lagarde M., Bernoud N., Brossard N., Lemaitre-Delaunay D., Thies F., Croset M., and Lecerf J. (2001). Lysophosphatidylcholine as a preferred carrier form of docosahexaenoic acid to the brain. J. Mol. Neurosci. 16:201–204.
Laposata M., Reich E.L., and Majerus P.W. (1985). Arachidonoyl-CoA synthetase. Separation from nonspecific acyl-CoA synthetase and distribution in various cells and tissues. J. Biol. Chem. 260:11016–11020.
Lauritzen L., Hansen H.S., Jorgensen M.H., and Michaelsen K.F. (2001). The essentiality of long chain n-3 fatty acids in relation to development and function of the brain and retina. Prog. Lipid Res. 40:1–94.
Lee H.J., Ghelardoni L., Chang L., Bosetti F., Rapoport S.I., and Bazinet R.P. (2005). Topiramate does not alter the kinetics of arachidonic or docosahexaenoic acid in brain phospholipids of the unanesthetized rat. Neurochem. Res. 30:677–683.
Lewin T.M., Kim J.H., Granger D.A., Vance J.E., and Coleman R.A. (2001). Acyl-CoA synthetase isoforms 1, 4, and 5 are present in different subcellular membranes in rat liver and can be inhibited independently. J. Biol. Chem. 276:24674–24679.
Li Q., Wang M., Tan L., Wang C., Ma J., Li N., Li Y., Xu G., and Li J.S. (2005). Docosahexaenoic acid changes lipid composition and interleukin-2 receptor signaling in membrane rafts. J. Lipid Res. 46:1904–1913.
Lin A.Y., Sun G.Y., and MacQuarrie R. (1984). Partial purification and properties of long-chain acyl-CoA hydrolase from rat brain cytosol. Neurochem. Res. 9:1571–1591.
Ma D.W.L., Seo J., Switzer K.C., Fan Y.Y., McMurray D.N., Lupton J.R., and Chapkin R.S. (2004). n-3 PUFA and membrane microdomains: a new frontier in bioactive lipid research. J. Nutr. Biochem. 15:700–706.
MacDonald J.I.S., and Sprecher H. (1991). Phospholipid fatty acid remodeling in mammalian cells. Biochim. Biophys. Acta 1084:105–121.
Martin R.E. (1998). Docosahexaenoic acid decreases phospholipase A2 activity in the neurites/nerve growth cones of PC12 cells. J. Neurosci. Res. 54:805–813.
Martin R.E., Wickham J.Q., Om A.S., Sanders J., and Ceballos N. (2000). Uptake and incorporation of docosahexaenoic acid (DHA) into neuronal cell body and neurite/nerve growth cone lipids: Evidence of compartmental DHA metabolism in nerve growth factor-differentiated PC12 cells. Neurochem. Res. 25:715–723.
Martínez M., and Mougan I. (1998). Fatty acid composition of human brain phospholipids during normal development. J. Neurochem. 71:2528–2533.
Marszalek J.R., Kitidis C., Dirusso C.C., and Lodish H.F. (2005). Long-chain acyl-CoA synthetase 6 preferentially promotes DHA metabolism. J. Biol. Chem. 280:10817–10826.
Mitchell D.C., Gawrisch K., Litman B.J., and Salem N., Jr. (1998). Why is docosahexaenoic acid essential for nervous system function? Biochem. Soc. Trans. 26:365–370.
Monier S., Dietzen D.J., Hastings W.R., Lubin D.M., and Korzchalia T.V. (1996). Oligomerization of VIP21-caveolin in vitro is stabilized by long chain fatty acylation or cholesterol. FEBS Lett. 388:143–149.
Nakamura M.T., and Nava T.Y. (2002). Gene regulation of mammalian desaturases. Biochem. Soc. Trans. 30:1076–1079.
Nakamura M.T., and Nara T.Y. (2004). Structure, function, and dietary regulation of delta6, delta5, and delta9 desaturases. Annu. Rev. Nutr. 24:345–376.
Nemazanyy I., Panasyuk G., Breus O., Zhyvoloup A., Filonenko V., and Gout IT. (2006). Identification of a novel CoA synthase isoform, which is primarily expressed in the brain. Biochem. Biophys. Res. Commun. 341:995–1000.
Niu S.L., Mitchell D.C., Lim S.Y., Wen Z.M., Kim H.Y., Salem N. Jr., and Litman B.J. (2004). Reduced G protein-coupled signaling efficiency in retinal rod outer segments in response to n-3 fatty acid deficiency. J. Biol. Chem. 279:31098–31104.
Norris A.W., and Spector A.A. (2002). Very long chain n-3 and n-6 polyunsaturated fatty acids bind strongly to liver fatty acid-binding protein. J. Lipid Res. 43:646–653.
Ojima A., Nakagawa Y., Sugiura T., Masuzawa Y., and Waku K. (1987). Selective transacylation of 1–0-alkylglycerophosphoethanolamine by docosahexaenoate and arachidonate in rat brain microsomes. J. Neurochem. 48:1403–1410.
Onuma Y., Masuzawa Y., Ishima Y., and Waku K. (1984). Selective incorporation of docosahexaenoic acid in rat brain. Biochim. Biophys. Acta 793:80–85.
Polozova A. Gionfriddo E., and Salem N. Jr. (2006). Effect of docosahexaenoic acid on tissue targeting and metabolism of plasma lipoproteins. Prostaglandins Leukot. Essent. Fatty Acids 75:183–190.
Polozova A., and Salem N. Jr. (2007). Role of liver and plasma lipoproteins in selective transport of n-3 fatty acids to tissues: a comparative study of 14C-DHA and 3H-oleic acid tracers. J. Mol. Neurosci. 33:56–66.
Pownall H.J. (2001). Cellular transport of nonesterified fatty acids. J. Mol. Neurosci. 16:109–115.
Prentki M., and Corkey B.E. (1996). Are the beta-cell signaling molecules malonyl-CoA and cystolic long-chain acyl-CoA implicated in multiple tissue defects of obesity and NIDDM? Diabetes. 45:273–283.
Rapoport S.I. (1999). In vivo fatty acid incorporation into brain phospholipids in relation to signal transduction and membrane remodeling. Neurochem. Res. 24:1403–1415.
Rapoport S.I., Chang M.C.J., and Spector A.A. (2001). Delivery and turnover of plasma-derived essential PUFAs in mammalian brain. J. Lipid Res. 42:678–685.
Rapoport S.I., Rao J.S., and Igarashi S. (2007). Brain metabolism of nutritionally essential polyunsaturated fatty acids depends on both the diet and the liver. Prostaglandins Leukot. Essent. Fatty Acids 77:251–261.
Rapoport S.I. (2007). Brain arachidonic and docosahexaenoic acid cascades are selectively altered by drugs, diet and disease. Prostaglandins Leukot. Essent. Fatty Acids 79:153–156.
Rapoport S.I. (2008). Arachidonic acid and the brain. J. Nutr. 138:2515–2520.
Reddy T.S., and Bazan N.G. (1984). Long-chain acyl coenzyme A synthetase activity during the postnatal development of the mouse brain. Int. J. Devl. Neurosci. 2:447–450.
Reddy T.S., Sprecher H., and Bazan N.G. (1984). Long-chain acyl-coenzyme A synthetase from rat brain microsomes. Kinetic studies using [1–14C]docosahexaenoic acid substrate. Eur. J. Biochem. 145:21–29.
Ross B.M., and Kish S.J. (1994). Characterization of lysophospholipid metabolizing enzymes in human brain. J. Neurochem. 63:1839–1848.
Rotstein N.P., Politi L.E., German O.L., and Girotti R. (2003). Protective effect of docosahexaenoic acid on oxidative stress-induced apoptosis of retina photoreceptors. Invest. Ophthalmol. Vis. Sci. 44:2252–2259.
Salem N. Jr., Kim H.Y., and Yergey J.A. (1986). Docosahexaenoic acid: membrane function and metabolism. In: Simopoulos A.P., Kifer R.R., and Martin R.E. (eds.), Health Effects of Polyunsaturated Fatty Acids in Seafoods, pp. 263–318. Academic Press, Orlando.
Salem N. Jr., Pawlosky R., Wegher B., and Hibbeln J. (1999). In vivo conversion of linoleic acid to arachidonic acid in human adults. Prostaglandins Leukot. Essent. Fatty Acids 60:407–410.
SanGiovanni J.P., and Chew E.Y. (2005). The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Prog. Retinal Eye Res. 24:87–138.
Schmidt A., Wolde M., Thiele C., Fest W., Kratzin H., Podtelejnikov A.V., Witke W., Huttner W.B., and Söling H.D. (1999). Endophilin I mediates synaptic vesicle formation by transfer of arachidonate to lysophosphatidic acid. Nature 401:133–141.
Scott B.L., and Bazan N.G. (1989). Membrane docosahexaenoate is supplied to the developing brain and retina by the liver. Proc. Natl. Acad. Sci. USA 86:2903–2907.
Shaikh S.R., Dumaual A.C., LoCassio D., Siddiqui R.A., and Stillwell W. (2003). Acyl chain unsaturation in PEs modulates phase separation from lipid raft molecules. Biochem. Biophys. Res. Commun. 311:793–796.
Shaikh, S.R. Dumaual A.C., Castillo A., LoCassio D., Siddiqui R.A., and Stillwell W., and Wassall S.R. (2004). Oleic and docosahexaenoic acid differentially phase separate from lipid raft molecules: A comparative NMR, DSC, AFM, and detergent extraction study. Biophys. J. 87:1752–1766.
Shikano M., Masuzawa Y., Yazawa K., Takayama K., Kudo I., and Inoue K. (1994). Complete discrimination of docosahexaenoate from arachidonate by 85 kDa cytosolic phospholipase A2 during the hydrolysis of diacyl- and alkenylacylglycerophosphoethanolamine. Biochim. Biophys. Acta 1212:211–216.
Shindou H., Hishikawa D., Harayama T., Yuki K., and Shimizu T. (2009). Recent progress on acyl CoA: lysophospholipid acyltransferase research. J. Lipid Res. 50 Suppl:S46-S51.
Simopoulos A.P. (2004). Omega-3 fatty acids and antioxidants in edible wild plants. Biol. Res. 37:263–277.
Simopoulos A.P. (2006). Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases. Biomed. Pharmacother. 60:502–507.
Söderberg M., Edlund C., Kristensson K., and Dallner G. (1991). Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease. Lipids 26:421–425.
Soupene E., and Kuypers F.A. (2008). Mammalian long-chain acyl-CoA synthetases. Exp. Biol. Med. (Maywood) 233:507–521.
Soupene Y., Chen Y.O., Bonacci T.M., Bredt D.S., Li S., Bensch W.R., Moller D.E., Kowala M., Konard R.J., and Cao G. (2008). Identification and characterization of a major liver lysophosphatidylcholine acyltransferase. J. Biol. Chem. 283:8258–8265.
Sprecher H., Chen Q., Yin F.Q. (1999). Regulation of the biosynthesis of 22:5n-6 and 22:6n-3: a complex intracellular process. Lipids 34(Suppl):S153–S156.
Stillwell W., Shaikh S.R., Zerouga M., Siddiqui R., and Wassall S.R. (2005). Docosahexaenoic acid affects cell signaling by altering lipid rafts. Reprod. Nutr. Develop. 45:559–579.
Stinson A.M., Wiegand R.D., and Anderson R.E. (1991). Fatty acid and molecular species compositions of phospholipids and diacylglycerols from rat retina membranes. Exp. Eye Res. 52:213–218.
Stoffel W., Holz B., Jenke B., Binczek E., Günter R.H. Kiss C., Karakesisoglou I., Thevis M., Weber A.A., Arnhold S., and Addicks K. (2008). Delta6-Desaturase (FADS2) deficiency unveils the role of omega3- and omega6-polyunsaturated fatty acids. EMBO J. 27:2281–2292.
Stremmel W., Pohl L., Ring A., and Herrman T. (2001). A new concept of cellular uptake and intracellular trafficking of long-chain fatty acids. Lipids 36:981–989.
Strokin M., Sergeeva M., and Reiser G. (2003). Docosahexaenoic acid and arachidonic acid release in rat brain astrocytes is mediated by two separate isoforms of phospholipase A2 and is differently regulated by cyclic AMP and Ca2+. Br. J. Pharmacol. 139:1014–1022.
Sun G.Y., and MacQuarrie R.A. (1989). Deacylation-reacylation of arachidonoyl groups in cerebral phospholipids. Ann. N.Y. Acad. Sci. 559:37–55.
Sun G.Y., and Su K.L. (1979). Metabolism of arachidonoyl phosphoglycerides in mouse brain sucellular fractions. J. Neurochem. 32:1053–1059.
Tsuge H., Hotta N., and Hayakawa T. (2000). Effects of vitamin B-6 on (n-3) polyunsaturated fatty acid metabolism. J. Nutr. 130(2S Suppl):333S–334S.
Utsunomiya A., Owada Y., Yoshimoto T., and Kondo H. (1997). Localization of mRNA for fatty acid transport protein in developing and mature brain of rats. Brain Res. Mol. Brain Res. 46:217–222.
Van Horn C.G., Caviglia M., Li L.O., Wang S., Granger D.A., and Coleman R.A. (2005). Characterization of recombinant long-chain rat acyl-CoA synthetase isoforms 3 and 6: identification of a novel variant of isoform 6. Biochemistry 44:1635–1644.
Vilaro S., Camps L., Reina M., Rerez-Clausell J., Llobera M., and Olivecrona T. (1990). Localization of lipoprotein lipase to discrete areas of the guinea pig brain. Brain Res. 506:249–253.
Visioli F., Crawford M.A., Cunnane S., Rise P., and Galli C. (2006). Lipid transport, dietary fats, and endogenous lipid synthesis: hypotheses on saturation and competition processes. Nutr. Health 18:127–132.
Wang Y., Botolin D., Christian B., Busik J., Xu J., and Jump D.B. (2005). Tissue-specific, nutritional, and developmental regulation of rat fatty acid elongases. J. Lipid Res. 46:706–715.
Washizaki K., Smith Q.R., Rapoport S.I., and Purdon A.D. (1994). Brain arachidonic acid incorporation and precursor pool specific activity during intravenous infusion of unesterified [3H]arachidonate in the anesthetized rat. J. Neurochem. 63:727–736.
Wassall S.R., Brzustowicz M.R., Shaikh S.R., Cherezov V., Caffrey M., and Stillwell W. (2004). Order from disorder, corralling cholesterol with chaotic lipids – The role of polyunsaturated lipids in membrane raft formation. Chem. Phys. Lipids 132:79–88.
Willumsen N., Hexeberg S., Skorve J., Lundquist M., and Berge R.K. (1993). Docosahexaenoic acid shows no triglyceride-lowering effects but increases the peroxisomal fatty acid oxidation in liver of rats. J. Lipid Res. 34:13–22.
Wolfgang M.J., Kurama T., Dai Y., Suwa A., Asaumi M., Matsumoto S., Cha S.H., Shimokawa T., and Lane M.D. (2006). The brain-specific carnitine palmitoyltransferase-1c regulates energy homeostasis. Proc. Natl. Acad. Sci USA 103:7282–7287.
Wolfgang M.J., Cha S.H., Millington D.S., Cline G., Shulman G.I., Suwa A., Asaumi M., Kurama T., Shimokawa T., and Lane M.D. (2008). Brain-specific carnitine palmitoyl-transferase-1c: role in CNS fatty acid metabolism, food intake, and body weight. J. Neurochem. 105:1550–1559.
Yamashita A., Sugiura T., and Waku K. (1997). Acyltransferases and transacylases involved in fatty acid remodeling of phospholipids and metabolism of bioactive lipids in mammalian cells. J. Biochem. (Tokyo) 122:1–16.
Yehuda S., Rabinovitz S., Carasso R.L., and Mostofsky D.I. (2002). The role of polyunsaturated fatty acids in restoring the aging neuronal membrane. Neurobiol. Aging 23:843–853.
Young C., Gean P.W., Chiou L.C., and Shen Y.Z. (2000). Docosahexaenoic acid inhibits synaptic transmission and epileptiform activity in the rat hippocampus. Synapse 37:90–94.
Zhang Q., Yoshida S., Sakai K., Liu J., and Fukunaga K. (2000). Changes of free fatty acids and acyl-CoAs in rat brain hippocampal slice with tetraethylammonium-induced long-term potentiation. Biochem. Biophys. Res. Commun. 267:208–212.
Zhao Y., Chen Y.O., Bonacci T.M., Bredt D.S., Li S., Bensch W.R., Moller D.E., Kowala M., Konard R.J., and Cao G. (2008). Identification and characterization of a major liver lysophosphatidylcholine acyltransferase. J. Biol. Chem. 283:8258–8265.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Farooqui, A.A. (2009). Transport, Synthesis, and Incorporation of n–3 and n–6 Fatty Acids in Brain Glycerophospholipids. In: Beneficial Effects of Fish Oil on Human Brain. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-0543-7_2
Download citation
DOI: https://doi.org/10.1007/978-1-4419-0543-7_2
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-0542-0
Online ISBN: 978-1-4419-0543-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)